Hims & Hers Health Inc HIMS

$28.06 -1.48 (-5.01%)

Valuation

Market cap
6,892,066,000
Revenue TTM
$2,347,640,000
Net income TTM
$128,370,000
PE ratio
0.00
Forward PE
—
Profit margin
5.47%
Debt to equity
0.00

Trading

Volume
15,049,000
Avg volume
11,130,708
Day's range
$27.49 – $29.62
Shares out
233,313,000
Stochastic %K
16%
Beta
2.44
Analysts
Sell
Price target
$31.77

Price

Company profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its we...

Show more

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
415 851 0195
Website
https://www.hims.com
Address
2269 Chestnut Street, Suite 523, San Francisco, United States

Latest news

Stocktwits

OnyxOracle Oct 9, 6:20 AM
$HIMS seeing some interesting volume lately. Makes you wonder if institutions are quietly building positions here. Anyone else tracking the ownership changes? Curious what the smart money sees that retail might be missing.
0 replies
RavvenTrading Oct 9, 5:47 AM
$HIMS 25$ to 32$
0 replies
SocialYoutube Oct 9, 4:15 AM
$HIMS Pretty sure Ro is not profitable on the 1-month and 3-month weight loss plans, and they are breakeven to low-single-digit profitable on the 6-month plan. Leaving only the 12-month plan, which makes any real profit for them. That seems to be the goal. First to be America's distribution channel wins the prize. Don't think this is sustainable, unless their OpEx, CAC, clinical expenses and insurance department costs are materially lower than what I'm modeling. We need a Ro interview like the good ole TechCrunch days. Where's a disgruntled employee when you need one?
0 replies
CrazyrichasianintheUSA Oct 9, 3:16 AM
$HIMS let’s go!!!
0 replies
BreakingBS Oct 9, 1:16 AM
$HIMS big money always wins. Sometimes you get to be part of the galactic move up. They are priming this stock.
0 replies
MorganChase Oct 8, 11:51 PM
$HIMS 💵💵💵💵💵💎💎💎💎💎
0 replies
Conke_Actual Oct 8, 10:43 PM
$HIMS
0 replies
VerifiedLemon Oct 8, 10:39 PM
Looking for a free small caps community? Click below ⭐ Amazing group of bulls sharing ideas and finding the big runners early. Check it out 🫡💯 Many adding $HIMS today
0 replies